Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-12-24

Clinical Trial Update: Safety and Efficacy Study of Intramuscular Uricase-PEG 20 [Phase 1]

View source ↗

Summary

This update reports on a Phase 1 safety and efficacy study of intramuscular Uricase-PEG 20 for gout and hyperuricemia. The study assesses preliminary safety and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Uricase-PEG 20 (uricase-peg-20)

Snippet

Sponsor: EnzymeRx | Conditions: Gout, Hyperuricemia | Phase 1 | Status: UNKNOWN